Canbi Pharma Tech Limited
558447-26-0 Mavorixafor

558447-26-0 Mavorixafor

Product name:Mavorixafor
CAS:558447-26-0
MF:C21H27N5
MW:349.47
EINECS:
MDL No.:MFCD11977316

Send Inquiry
Description

Properties

Appearance brown oil
Melting point:108-110℃
Boiling point:597.0±50.0 °C
Density 1.21
storage temp. Store at -20°C

 

Application:

    Mavorixafur is a selective CXC chemokine receptor 4 (CXCR4) antagonist primarily used for the treatment of WHIM syndrome patients aged 12 years and older. Mavorixafur inhibits the excessive transmission of the CXCR4/CXCL12 signaling pathway by blocking the binding between CXCR4 and its ligand CXCL12 (also known as SDF-1), thereby increasing the number of mature neutrophils and lymphocytes in the bloodstream and helping to improve the patient's immune function.

 

Synonyms:

558447-26-0

AMD-070

Mavorixafor

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

X4P-001

N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine

1,4-BUTANEDIAMINE, N-(1H-BENZIMIDAZOL-2-YLMETHYL)-N-((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)-

N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

 

Hot Tags: 558447-26-0 mavorixafor, China 558447-26-0 mavorixafor manufacturers, suppliers, api role based access control api integration, api restaurant api integration, api machine learning integration, api banking api integration, Cefprozil hydrate, api order management api integration

Inquiry
goTop

(0/10)

clearall